AzTrials
AzTrials

Stress, PsychologicalNCT03881631

Improving Well-Being for Older Adult Family Dementia Caregivers

A study testing Mindfulness Based Stress Reduction Program and Living Well Program in people with Stress, Psychological, run by University of Rochester at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will examine the effects of the Mindfulness-Based Stress Reduction (MBSR) program and the Living Well program, compared to a control group, to see if the programs might be associated with better immune function (response to current influenza vaccine), physical and emotional health, and well-being. Read more about this study

Who is it for?
Ages 55 years and olderHealthy volunteers can take part
Conditions the study is for
Stress, Psychological
What is being tested?
Mindfulness Based Stress Reduction Program and Living Well Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
142 participants
Where
1 siteUnited States
Study dates
18 Jul 2016to 3 May 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 55 years of age and older
  • English-speaking (consent process and assessments will be conducted in English only)
  • Currently living with or in proximity to, and the primary caregiver for, a loved one with dementia who lives in the community-for the purposes of this study, "loved one" refers to a family member such as a spouse, ex-spouse, significant other, sibling, in-law, parent, or other type of close established relationship (e.g., close friend) regarded as family; "primary caregivers" provide daily informal (non-paid) in-person care.
  • Currently experiencing moderate to high levels of perceived stress (PSS-10 ≥ 12) and/or caregiver burden (MCSI ≥ 5)
  • Participants will be asked to stabilize medications prior to beginning the trial, and for the duration of the trial (If medication dose changes do occur, analytic models will include those changes as time-varying covariates)

Who cannot join

  • Loved one with dementia currently resides in a long-term care facility (e.g., nursing home) without the caregiver.
  • Given the didactic and self-directed nature of the MBSR program, individuals with major, uncorrected sensory impairments and cognitive deficits, as determined by a Montreal Cognitive Assessment (MoCA) score of 23 or lower 29, will be excluded, as will participants with other neuropsychological deficits deemed significant enough to interfere with study participation. Low literacy is not an exclusion criterion; questionnaires will be orally administered when necessary.
  • Modules from the Mini International Neuropsychiatric Exam (MINI 30) will be used to exclude subjects who have these psychiatric conditions: current alcohol dependence, current non-alcohol psychoactive substance use dependence, psychotic disorders (current and lifetime), bipolar disorder, and current mood disorder with psychotic features.
  • Subjects will also be excluded for the following reasons: having completed an MBSR program in the past; allergy to eggs (the influenza vaccine is most commonly manufactured using an egg-based process); history of Guillain-Barré syndrome; immunodeficiency or receipt of immunosuppressive therapy; recent major surgery; and active neoplastic disease.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Rochester Medical Center

    Rochester, New York, 14642

Other trials in United States

About this study

Official title: Mindfulness-Based Stress Reduction for Family Caregivers of Dementia Patients

This study will examine the effects of the Mindfulness-Based Stress Reduction (MBSR) program and the Living Well program, compared to a control group, to see if the programs might be associated with better immune function (response to current influenza vaccine), physical and emotional health, and well-being.

Read the detailed description

A considerable literature documents that a wide variety of psychosocial interventions can lessen the psychological burden of family or spousal dementia caregiving. Some caregiver intervention studies have included measures of self-reported physical health and sleep, and others have focused on improving inflammation in caregivers. The current study will add to this literature by examining the effects of two behavioral interventions on adaptive immune responses, particularly, antibody response to influenza vaccination, in older adult family caregivers.

Being tested
Mindfulness Based Stress Reduction Program, Living Well Program
Medical subject headings
Stress, Psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mindfulness Based Stress Reduction ProgramBehavioural

    Also called MBSR

    Group-based intervention

  • Living Well ProgramBehavioural

    Group-based intervention

Study groups in NCT03881631
Study groupRoleWhat they receive
Mindfulness Based Stress Reduction (MBSR) ProgramExperimentalThe MBSR program is an eight-week-long course designed to teach subjects how to develop their inner resources in the service of taking better care of themselves. MBSR training includes the learning and refining of a range of skills aimed at increasing relaxation and awareness of physical experiences and sensations related to physical symptoms, emotions, and thoughts. Special emphasis is placed on movement, meditation, and breathing.
Receives: Behavioral: Mindfulness Based Stress Reduction Program
Living Well (LW) ProgramActive comparatorLW is an eight-week course of group presentations and discussions on topics related to the promotion of health and well-being in the context of dementia caregiving. LW is designed to teach participants how to improve their physical and emotional health as a complement to traditional medical treatments.
Receives: Behavioral: Living Well Program
Usual CareNo interventionThe usual care arm is a no intervention group wherein participants experience their usual circumstances.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Antibody response to influenza vaccination

    Change in amount of antibody titers following influenza vaccination

    Measured: pre-vaccination to 6 weeks and 6 months post-vaccination

Secondary outcomes (3)
  1. Granzyme B (GrzB) activity after influenza vaccination

    Change in GrzB activity, a measure of antigen-specific cytotoxic T cell activity, following influenza vaccination

    Measured: pre-vaccination to 6 weeks and 6 months post-vaccination

  2. Ratio of T-cell cytokines, interferon (IFN)-gamma and IL-10

    Change in IFN:IL-10 ratio following influenza vaccination

    Measured: pre-vaccination to 6 weeks and 6 months post-vaccination

  3. Inflammatory cytokines, interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha

    Change in inflammatory cytokine levels over time

    Measured: baseline to 6 weeks to 6 months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Mar 2019
  2. Study start18 Jul 2016
  3. Primary completion3 May 2023
  4. Study completion3 May 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Factorial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
142 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03881631
Sponsor's protocol ID
STUDY00000881
Other IDs
R01AG052495
Status last verified
May 2023
First submitted
15 Mar 2019
Last updated
8 May 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data sharing is in accordance with NIH Data Sharing Policy.

Questions about this trial

What is this clinical trial studying?

A study testing Mindfulness Based Stress Reduction Program and Living Well Program in people with Stress, Psychological, run by University of Rochester at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Antibody response to influenza vaccination (time frame: pre-vaccination to 6 weeks and 6 months post-vaccination). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in